Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Classifica tra le azioni #27877
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Prezzo delle azioni
$0.04861197
Capitalizzazione di mercato
$30.02M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-91.39%
Paese
CN
Scambia Immunotech Biopharm Ltd (6978)

Categoria

Storico del prezzo dell'azione per Immunotech Biopharm Ltd (6978)
Prezzo di chiusura più alto: $0.05 il 2026-08-01

Prezzo di chiusura più basso: $1.62 il 2020-07-01
Storico del prezzo dell'azione di Immunotech Biopharm Ltd dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -16.15%
2025 18.05%
2024 -39.42%
2023 -16.02%
2022 -68.58%
2021 55.17%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.58 -14.39%
AU
$753.28 5.84%
CH